Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.
about
The evolution of poxvirus vaccinesHepatitis B: future curative strategiesPartially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentComputational evolutionary analysis of the overlapped surface (S) and polymerase (P) region in hepatitis B virus indicates the spacer domain in P is crucial for survivalA human multi-epitope recombinant vaccinia virus as a universal T cell vaccine candidate against influenza virusEpidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural NigeriaA broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens.Strategies to eliminate HBV infection.Plasmodium immunomics.Broad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides.The signal peptide sequence impacts the immune response elicited by a DNA epitope vaccine.A novel tuberculosis DNA vaccine in an HIV-1 p24 protein backbone confers protection against Mycobacterium tuberculosis and simultaneously elicits robust humoral and cellular responses to HIV-1Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.Cancer genome sequencing and its implications for personalized cancer vaccines.Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective.Therapeutic vaccination and novel strategies to treat chronic HBV infection.Immunogenicity of a Multi-Epitope DNA Vaccine Encoding Epitopes from Cu-Zn Superoxide Dismutase and Open Reading Frames of Brucella abortus in Mice.On the future of HLA.Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?Therapeutic vaccines in HBV: lessons from HCV.Advances in therapeutics for chronic hepatitis B.Novel insights into immunotherapy for hepatitis B patients.Treatment of hepatitis B virus: an update.Design and production of a multiepitope construct derived from hepatitis E virus capsid protein.HLA-A*31 as a marker of genetic susceptibility to sepsis.Generation of a Novel HLA Class I Transgenic Mouse Model Carrying a Knock-in Mutation at the β2-Microglobulin Locus.A phase 1, randomized, controlled dose-escalation study of EP-1300 polyepitope DNA vaccine against Plasmodium falciparum malaria administered via electroporation.Woodchuck hepatitis virus core gene deletions and proliferative responses of peripheral blood mononuclear cells stimulated by an immunodominant epitope: a viral immune escape in the woodchuck model of chronic hepatitis B?Designing string-of-beads vaccines with optimal spacers.Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice.Resistance-associated epitopes of HIV-1C-highly probable candidates for a multi-epitope vaccine.Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.Identification and immunogenic potential of B cell epitopes of outer membrane protein OmpF of Aeromonas hydrophila in translational fusion with a carrier protein.GENimmune NV.Immune responses of human T lymphocytes to novel hepatitis B virus-derived peptides.Tools for Vaccine Design: Prediction and Validation of Highly Immunogenic and Conserved Class II Epitopes and Development of Epitope-Driven Vaccines
P2860
Q26995905-E87E8344-595F-4BF8-A2DC-571C7300AB63Q27011623-4287580A-7ED5-4DF4-B96C-776E2CA24425Q28742762-B67BCC1B-1CD5-45CA-B733-1593D1F2797DQ30226873-4EEB3840-EF0A-469E-87B7-DF7D5DC3A100Q30429273-B761ABCC-66AB-4890-B2CC-91EAA9E445C0Q31037728-9D86A807-0C4F-4BE3-AD9D-D19A55D79B0AQ33349504-BC7F2DCA-49C1-48E7-8A36-7B66280F29B9Q34004266-EAE1F64F-F30E-4CAF-BB40-94D5899ACF10Q34308129-70192781-EDD2-4D80-B092-AD647BC7AB52Q34419934-6F59CEAF-85D1-4EE6-9C43-E1D2EBC24F96Q34428561-D4EC9BBB-BCA4-4BD1-90E6-87C34A93F873Q35271066-1684F92B-B481-45B2-9E8C-96A91D9BCA46Q35940744-6A3DE48A-DC0C-4CF7-BCC2-757011F943C5Q36949834-D1D4D36B-B964-4292-953E-BD9902385920Q37148184-7EBFC6F9-019A-41D5-947E-CF17633758E8Q37195244-27C2454B-ABCF-4523-A6E3-10F3D0D69444Q37611862-CC0BFAF2-EDEB-4401-8995-FA059F094C61Q37632905-BBE4FCFA-F2CD-4435-91BE-5213824E56DEQ37935058-3E5E5698-AF4F-4199-8C78-A2496B4B3DB9Q38289729-3E20C0D6-9A54-4094-91F6-A3AE61E6F24EQ38312255-479AF02D-A8FE-47E4-B0E5-5E6901AE0650Q38585657-6B0B118C-4E5F-4C9F-9363-DD67F2B3990CQ38655228-4DEA0EF4-FEA6-4977-950E-9A05FE1C4159Q38794446-E81CD70D-4FFF-4FF5-B4B1-4386A8E0355BQ39027960-6328CF0B-BC97-40D1-956F-FB188CE6343DQ39894355-1B7566B2-508A-46B2-B690-FD5C77399829Q40459585-8C207DE1-9CFB-492B-B84F-4F91ACB20848Q40491101-C7C00229-B706-4E7A-941C-A74E3263E15FQ41493609-E3EF49CF-1694-4845-8676-6D4A4AD0DB66Q41874594-13FD77CD-26FC-44A0-AD9E-D7285E7934B1Q42148071-ADC9FD99-C7AC-4080-A323-4202E780557AQ44734756-84D7CD17-4DE5-47B5-93AA-F31E78EA6141Q45356792-DD72ABDA-496F-46D5-AF69-8D13D0B6CA13Q51013156-23F16527-C0E2-4275-9077-E75A8F73D2F3Q54202525-5E94194B-300C-416F-96C8-50D4894B2AE8Q55257705-48BAB418-C312-41AA-9E24-009F405EEABCQ57537566-2DEBD24B-DFED-468A-B695-1316C93DBCD3
P2860
Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Rational design of a multiepit ...... hepatitis B virus infections.
@ast
Rational design of a multiepit ...... hepatitis B virus infections.
@en
type
label
Rational design of a multiepit ...... hepatitis B virus infections.
@ast
Rational design of a multiepit ...... hepatitis B virus infections.
@en
prefLabel
Rational design of a multiepit ...... hepatitis B virus infections.
@ast
Rational design of a multiepit ...... hepatitis B virus infections.
@en
P2093
P2860
P356
P1433
P1476
Rational design of a multiepit ...... hepatitis B virus infections.
@en
P2093
Annegret Van der Aa
Brian D Livingston
Carol Dahlberg
Claire Crimi
Denise McKinney
Erik Depla
Jonathan Krakover
Koen Allosery
Lilia Babé
Lydie Meheus
P2860
P304
P356
10.1128/JVI.01505-07
P407
P577
2007-10-17T00:00:00Z